Abnormal expression of p120 correlates with poor survival in patients with bladder cancer

European Journal of Cancer

Volumn 34, Issue 13, 1998, Pages 2037-2040

  Syrigos, K N ^a,b   Karayiannakis, A ^a   Syrigou, E I ^a   Harrington, K ^b   Pignatelli, M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Department of Medical Oncology ^*

Author keywords

Bladder cancer; E cadherin; P120; Prognostic marker

Indexed keywords

CELL ADHESION MOLECULE; PROTEIN P120; UNCLASSIFIED DRUG; UVOMORULIN;

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CANCER; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CELLULAR DISTRIBUTION; CYTOSKELETON; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TRANSITIONAL CELL CARCINOMA;

AGED; CADHERINS; CELL ADHESION MOLECULES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM PROTEINS; PHOSPHOPROTEINS; PROGNOSIS; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 0032402441     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00279-2     Document Type: Article

References (32)

1. 1. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991, 251, 1451-1455.
2. 2. Gumbiner BM, McCrea PD. Catenins as mediators of the cytoplasmic functions of cadherins. J Cell Sci 1993, 17, 155-158.
3. 3. Hinck L, Näthke IS, Papkoff J, Nelson WJ. Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly. J Cell Biol 1994, 125, 1327-1340.
4. 4. Reynolds AB, Herbert L, Cleveland JL, Berg ST, Gaut JR. p 120, a novel substrate of protein tyrosine kinase receptors and of p60v-src, is related to cadherin-binding factors b-catenin, plakoglobin and armadillo. Oncogene 1992, 7, 2439-2445.
5. 5. Reynolds AB, Daniel J, McCrea PD, Wheelock MJ, Wu J, Zhang Z. Identification of a new catenin: the tyrosine kinase substrate p120cas associates with E-cadherin complexes. Mol Cell Biol 1994, 14, 8333-8342.
6. 6. Shibamoto S, Hayakawa M, Takeuchi K, et al. Association of p120, a tyrosine kinase substrate, with E-cadherin/catenin complexes. J Cell Biol 1995, 128, 949-957.
7. 7. Oka H, Shiozaki H, Kobayashi K, et al. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 1993, 53, 1696-1701.
8. 8. Nigam AK, Savage FJ, Boulos PB, Stamp GWH, Liu D, Pignatelli M. Loss of cell-cell and cell-matrix adhesion molecules in colorectal cancer. Br J Cancer 1993, 68, 507-514.
9. 9. Umbas R, Schalken JA, Aalders TW, et al. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high grade prostate cancer. Cancer Res 1992, 52, 5104-5109.
10. 10. Pignatelli M, Ansari TW, Gunter P, et al. Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade and advanced stage. J Pathol 1994, 174, 243-248.
11. 11. Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K, Birchmeier W. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res 1991, 51, 6328-6337.
12. 12. Mattijssen V, Peters HM, Schalkwijk L, et al. E-cadherin expression in head and neck squamous cell carcinoma is associated with clinical outcome. Int J Cancer 1993, 55, 580-585.
13. 13. Syrigos KN, Krausz T, Waxman J, et al. E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues: correlation with histopathological grade and tumour stage and survival. Int J Cancer 1995, 64, 367-370.
14. 14. Bringuier PP, Umbas R, Schaafsma E, Karthaus HFM, deBruyne FMJ, Schalken JA. Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res 1993, 53, 3241-3245.
15. 15. Frixen V, Behrens J, Sachs M, et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991, 113, 173-185.
16. cas) in bladder tumors. Cancer Res 1996, 56, 4154-4158.
17. 17. Mostofi FK, Sobin LH, Torloni H. Histological typing of urinary bladder tumours. In International Histological Classification of Tumours, 10. Geneva, World Health Organisation, 1973.
18. 18. Heiken JP, Forman HP, Brown JJ. Neoplasms of the bladder, prostate and testis. Radiol Clin North Am 1994, 32, 81-98.
19. 19. Silverberg E, Boring CC, Squires TS. Cancer statistics 1990. CA Cancer J Clin 1990, 40, 9-26.
20. 20. Narayana AS, Loening SA, Slymen DJ, Culp DA. Bladder cancer: factors affecting survival. J Urol 1983, 130, 56-60.
21. 21. Abel PD, Henderson D, Bennett MK, Hall RR, Williams G. Differing interpretations by pathologist of the pT category and grade of transitional cell cancer of the bladder. Br J Urol 1988, 62, 339-342.
22. 22. Ooms EC, Anderson WA, Alons CL, Boon ME, Veldhuizen RW. Analysis of the performance of pathologists in the grading of bladder tumors. Hum Pathol 1983, 14, 140-143.
23. 23. Behrens J. Cell contacts, differentiation and invasiveness of epithelial cells. Invasion-Metastasis 1994, 14, 61-70.
24. 24. Rebel JM, Thijssen CD, Vermey M, Delouvee A, Zwarthoff EC, Van-der-Kwast TH. E-cadherin expression determines the mode of replacement of normal urothelium by human bladder carcinoma cell lines. Cancer Res 1994, 54, 5488-5492.
25. 25. Ross JS, del-Rosario AD, Figge HL, Sheehan C, Fisher HA, Bui HX. E-cadherin expression in papillary transitional cell carcinoma of the urinary bladder. Hum Pathol 1995, 26, 940-944.
26. 26. Daniel JM, Reynolds AB. The tyrosine kinase substrate p120cas binds directly to E-cadherin but not to the adenomatous polyposis coli protein or a-catenin. Mol Cell Biol 1995, 15, 4819-4824.
27. 27. Downing JR, Reynolds AB. PDGF, CSF-1, and EGF induced tyrosine phosphorylation of p120, a pp60src transformation-associated substrate. Oncogene 1991, 6, 607-613.
28. 28. Shibamoto S, Hayakawa M, Takeuchi K, et al. Tyrosine phosphorylation of β-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. Cell Adhes Commun 1994, 1, 295-305.
29. 29. Dignass AU, Lynch-Devaney K, Podolsky DK. Hepatocyte growth factor/scatter factor modulates intestinal epithelial cell proliferation and migration. Biochem Biophys Res Commun 1994, 202, 701-709.
30. 30. Rubinfeld B, Souza B, Albert I, Munemitsu S, Polakis P. The APC protein and E-cadherin form similar but independent complexes with a-catenin, β-catenin and plakoglobin. J Biol Chem 1995, 270, 5549-5555.
31. 31. Shibata T, Gotoh M, Ochiai A, Hirohashi S. Association of plakoglobin with APC, a tumour suppressor gene product and its regulation by tyrosine phosphorylation. Biochem Biophys Res Commun 1994, 203, 519-522.
32. 32. Migdley CA, White S, Howitt R. APC expression in normal human tissues. J Pathol 1997, 181, 426-433.